Condition: Breast Neoplasms · Sponsor: BioNTech SE
This is a Phase III trial where participants will be randomized to two treatment groups, which means participants will be assigned by equal chance to a treatment group. This trial will be double-blinded, which means neither the participants nor the trial doctors will know which of the two treatments the participants actually receive. Participants will receive either the trial drug with chemotherapy or placebo (which looks like the trial drug but does not have any drug in it) with chemotherapy.
This description comes directly from the study's public registry record.
BioNTech clinical trials patient information · +49 6131 9084 · patients@biontech.de
Always discuss trial participation with your own doctor first.
| Highlands Oncology Group | Springdale, Arkansas, United States | Recruiting |
| University Of California - San Diego Moores Cancer Center | La Jolla, California, United States | Recruiting |
| Cedar Sinai - Samuel Oschin Cancer Center | Los Angeles, California, United States | Recruiting |
| Stanford University School of Medicine - Stanford Cancer Institute (SCI) - Stanford Women's Cancer Center | Palo Alto, California, United States | Recruiting |
| Sacred Heart Medical Oncology Group | Pensacola, Florida, United States | Recruiting |
| Cancer Care Specialists | Decatur, Illinois, United States | Recruiting |
| Cancer Care Specialists of Illinois | O'Fallon, Illinois, United States | Recruiting |
| Carle Foundation Hospital d/b/a Carle Cancer Center | Urbana, Illinois, United States | Recruiting |
| University Medical Center, Inc. DBA University of Louisville Hospital/James Graham Brown Cancer Center | Louisville, Kentucky, United States | Recruiting |
| New England Cancer Specialists | Westbrook, Maine, United States | Recruiting |
| Saint Agnes Hospital, Clinical Research Center | Baltimore, Maryland, United States | Recruiting |
| Lahey Hospital & Medical Center | Burlington, Massachusetts, United States | Recruiting |
+ 143 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07173751